Teresa Barcina Lacosta

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Advanced Cancer

Rheumatoid Arthritis Patients

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Pharmaceuticals (Basel, Switzerland)

KU Leuven

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven

Belgium

PhD researcher :: Clinical Pharmacology and Pharmacotherapy

Publications

Teresa Barcina Lacosta, Arnold G Vulto, Florian Turk, Isabelle Huys, Steven Simoens
Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Teresa Barcina Lacosta, Arnold G Vulto, Florian Turk, Isabelle Huys, Steven Simoens
Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (3) (2024)
Teresa Barcina Lacosta, Arnold G Vulto, Adina Turcu-Stiolica, Isabelle Huys, Steven R A Simoens
Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across Europe. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (2) (2022)
Evelien Moorkens, Teresa Barcina Lacosta, Arnold G Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert W Selke, Isabelle Huys, Steven R A Simoens
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany. Pharmaceuticals (Basel, Switzerland) 13 (10) (2020)